fairplay™ microarray labeling kit Search Results


gsa 300 microarray random priming labeling kit  (Abbott Laboratories)
90
Abbott Laboratories gsa 300 microarray random priming labeling kit
Gsa 300 Microarray Random Priming Labeling Kit, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gsa 300 microarray random priming labeling kit/product/Abbott Laboratories
Average 90 stars, based on 1 article reviews
gsa 300 microarray random priming labeling kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
3dna 350s hs labeling kit  (Genisphere llc)
90
Genisphere llc 3dna 350s hs labeling kit
3dna 350s Hs Labeling Kit, supplied by Genisphere llc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/3dna 350s hs labeling kit/product/Genisphere llc
Average 90 stars, based on 1 article reviews
3dna 350s hs labeling kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
microarray platform flashtag biotin hsr labelling kit  (Genisphere llc)
90
Genisphere llc microarray platform flashtag biotin hsr labelling kit
Microarray Platform Flashtag Biotin Hsr Labelling Kit, supplied by Genisphere llc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/microarray platform flashtag biotin hsr labelling kit/product/Genisphere llc
Average 90 stars, based on 1 article reviews
microarray platform flashtag biotin hsr labelling kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
mirna microarray system labeling kit  (Illumina Inc)
90
Illumina Inc mirna microarray system labeling kit
Differentially expressed mRNAs and miRNAs were identified according to -fold changes in expression and p -value criteria. <t>MiRNA-targeted</t> gene pairs were identified using miRNAs and mRNAs differentially expressed in NMIBC and MIBC versus normal tissue according to previously validated informations regarding mRNA-miRNA interactions. NMIBC, non-muscle invasive bladder cancer; MIBC, muscle invasive bladder cancer.
Mirna Microarray System Labeling Kit, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mirna microarray system labeling kit/product/Illumina Inc
Average 90 stars, based on 1 article reviews
mirna microarray system labeling kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
circrna microarray labeling kit  (Arraystar inc)
90
Arraystar inc circrna microarray labeling kit
Differentially expressed mRNAs and miRNAs were identified according to -fold changes in expression and p -value criteria. <t>MiRNA-targeted</t> gene pairs were identified using miRNAs and mRNAs differentially expressed in NMIBC and MIBC versus normal tissue according to previously validated informations regarding mRNA-miRNA interactions. NMIBC, non-muscle invasive bladder cancer; MIBC, muscle invasive bladder cancer.
Circrna Microarray Labeling Kit, supplied by Arraystar inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/circrna microarray labeling kit/product/Arraystar inc
Average 90 stars, based on 1 article reviews
circrna microarray labeling kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
cdna synthesis and labeling kit for microarray hybridization  (Arraystar inc)
90
Arraystar inc cdna synthesis and labeling kit for microarray hybridization
Differentially expressed mRNAs and miRNAs were identified according to -fold changes in expression and p -value criteria. <t>MiRNA-targeted</t> gene pairs were identified using miRNAs and mRNAs differentially expressed in NMIBC and MIBC versus normal tissue according to previously validated informations regarding mRNA-miRNA interactions. NMIBC, non-muscle invasive bladder cancer; MIBC, muscle invasive bladder cancer.
Cdna Synthesis And Labeling Kit For Microarray Hybridization, supplied by Arraystar inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cdna synthesis and labeling kit for microarray hybridization/product/Arraystar inc
Average 90 stars, based on 1 article reviews
cdna synthesis and labeling kit for microarray hybridization - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
aminoallyl labeling kit for dna microarrays  (Arrayit Corporation)
90
Arrayit Corporation aminoallyl labeling kit for dna microarrays
Differentially expressed mRNAs and miRNAs were identified according to -fold changes in expression and p -value criteria. <t>MiRNA-targeted</t> gene pairs were identified using miRNAs and mRNAs differentially expressed in NMIBC and MIBC versus normal tissue according to previously validated informations regarding mRNA-miRNA interactions. NMIBC, non-muscle invasive bladder cancer; MIBC, muscle invasive bladder cancer.
Aminoallyl Labeling Kit For Dna Microarrays, supplied by Arrayit Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/aminoallyl labeling kit for dna microarrays/product/Arrayit Corporation
Average 90 stars, based on 1 article reviews
aminoallyl labeling kit for dna microarrays - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
mircury microarray labeling kit  (Qiagen)
90
Qiagen mircury microarray labeling kit
miR-19a is upregulated in the hypoxia-exposed CRC cells: (a) differentially expressed miRNAs between CRC cells cultured under hypoxic and normoxic conditions screened using a <t>microarray</t> analysis; (b) expression of miR-19a in HCT116 and SW480 cells cultured under hypoxic and normoxic conditions validated by RT-qPCR ( ∗ p < 0.05, two-way ANOVA); (c) expression of miR-19a in cancer and paracancerous tissues from CRC patients examined by RT-qPCR ( ∗ p < 0.05, paired t -test); (d) relevance of miR-19a expression to the survival of patients ( ∗ p < 0.05, Kaplan-Meier analysis); (e) relevance of miR-19a expression to the clinical characteristics of patients; (f) expression of miR-19a in HCT116 and SW480 and in normal NCM460 cells determined by RT-qPCR ( ∗ p < 0.05, one-way ANOVA). Data were presented as the mean ± SD from three independent experiments.
Mircury Microarray Labeling Kit, supplied by Qiagen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mircury microarray labeling kit/product/Qiagen
Average 90 stars, based on 1 article reviews
mircury microarray labeling kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
array 350 microarray labeling kit  (Genisphere llc)
90
Genisphere llc array 350 microarray labeling kit
miR-19a is upregulated in the hypoxia-exposed CRC cells: (a) differentially expressed miRNAs between CRC cells cultured under hypoxic and normoxic conditions screened using a <t>microarray</t> analysis; (b) expression of miR-19a in HCT116 and SW480 cells cultured under hypoxic and normoxic conditions validated by RT-qPCR ( ∗ p < 0.05, two-way ANOVA); (c) expression of miR-19a in cancer and paracancerous tissues from CRC patients examined by RT-qPCR ( ∗ p < 0.05, paired t -test); (d) relevance of miR-19a expression to the survival of patients ( ∗ p < 0.05, Kaplan-Meier analysis); (e) relevance of miR-19a expression to the clinical characteristics of patients; (f) expression of miR-19a in HCT116 and SW480 and in normal NCM460 cells determined by RT-qPCR ( ∗ p < 0.05, one-way ANOVA). Data were presented as the mean ± SD from three independent experiments.
Array 350 Microarray Labeling Kit, supplied by Genisphere llc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/array 350 microarray labeling kit/product/Genisphere llc
Average 90 stars, based on 1 article reviews
array 350 microarray labeling kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
array 00mpxtm cdna microarray labeling kit  (Genisphere llc)
90
Genisphere llc array 00mpxtm cdna microarray labeling kit
miR-19a is upregulated in the hypoxia-exposed CRC cells: (a) differentially expressed miRNAs between CRC cells cultured under hypoxic and normoxic conditions screened using a <t>microarray</t> analysis; (b) expression of miR-19a in HCT116 and SW480 cells cultured under hypoxic and normoxic conditions validated by RT-qPCR ( ∗ p < 0.05, two-way ANOVA); (c) expression of miR-19a in cancer and paracancerous tissues from CRC patients examined by RT-qPCR ( ∗ p < 0.05, paired t -test); (d) relevance of miR-19a expression to the survival of patients ( ∗ p < 0.05, Kaplan-Meier analysis); (e) relevance of miR-19a expression to the clinical characteristics of patients; (f) expression of miR-19a in HCT116 and SW480 and in normal NCM460 cells determined by RT-qPCR ( ∗ p < 0.05, one-way ANOVA). Data were presented as the mean ± SD from three independent experiments.
Array 00mpxtm Cdna Microarray Labeling Kit, supplied by Genisphere llc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/array 00mpxtm cdna microarray labeling kit/product/Genisphere llc
Average 90 stars, based on 1 article reviews
array 00mpxtm cdna microarray labeling kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
jinxin prokaryotes microarray labeling kit  (CapitalBio Corporation)
90
CapitalBio Corporation jinxin prokaryotes microarray labeling kit
miR-19a is upregulated in the hypoxia-exposed CRC cells: (a) differentially expressed miRNAs between CRC cells cultured under hypoxic and normoxic conditions screened using a <t>microarray</t> analysis; (b) expression of miR-19a in HCT116 and SW480 cells cultured under hypoxic and normoxic conditions validated by RT-qPCR ( ∗ p < 0.05, two-way ANOVA); (c) expression of miR-19a in cancer and paracancerous tissues from CRC patients examined by RT-qPCR ( ∗ p < 0.05, paired t -test); (d) relevance of miR-19a expression to the survival of patients ( ∗ p < 0.05, Kaplan-Meier analysis); (e) relevance of miR-19a expression to the clinical characteristics of patients; (f) expression of miR-19a in HCT116 and SW480 and in normal NCM460 cells determined by RT-qPCR ( ∗ p < 0.05, one-way ANOVA). Data were presented as the mean ± SD from three independent experiments.
Jinxin Prokaryotes Microarray Labeling Kit, supplied by CapitalBio Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/jinxin prokaryotes microarray labeling kit/product/CapitalBio Corporation
Average 90 stars, based on 1 article reviews
jinxin prokaryotes microarray labeling kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
jinxin1 prokaryotes microarray labeling kit  (CapitalBio Corporation)
90
CapitalBio Corporation jinxin1 prokaryotes microarray labeling kit
miR-19a is upregulated in the hypoxia-exposed CRC cells: (a) differentially expressed miRNAs between CRC cells cultured under hypoxic and normoxic conditions screened using a <t>microarray</t> analysis; (b) expression of miR-19a in HCT116 and SW480 cells cultured under hypoxic and normoxic conditions validated by RT-qPCR ( ∗ p < 0.05, two-way ANOVA); (c) expression of miR-19a in cancer and paracancerous tissues from CRC patients examined by RT-qPCR ( ∗ p < 0.05, paired t -test); (d) relevance of miR-19a expression to the survival of patients ( ∗ p < 0.05, Kaplan-Meier analysis); (e) relevance of miR-19a expression to the clinical characteristics of patients; (f) expression of miR-19a in HCT116 and SW480 and in normal NCM460 cells determined by RT-qPCR ( ∗ p < 0.05, one-way ANOVA). Data were presented as the mean ± SD from three independent experiments.
Jinxin1 Prokaryotes Microarray Labeling Kit, supplied by CapitalBio Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/jinxin1 prokaryotes microarray labeling kit/product/CapitalBio Corporation
Average 90 stars, based on 1 article reviews
jinxin1 prokaryotes microarray labeling kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Differentially expressed mRNAs and miRNAs were identified according to -fold changes in expression and p -value criteria. MiRNA-targeted gene pairs were identified using miRNAs and mRNAs differentially expressed in NMIBC and MIBC versus normal tissue according to previously validated informations regarding mRNA-miRNA interactions. NMIBC, non-muscle invasive bladder cancer; MIBC, muscle invasive bladder cancer.

Journal: Oncotarget

Article Title: Identification of differentially expressed miRNAs and miRNA-targeted genes in bladder cancer

doi: 10.18632/oncotarget.24441

Figure Lengend Snippet: Differentially expressed mRNAs and miRNAs were identified according to -fold changes in expression and p -value criteria. MiRNA-targeted gene pairs were identified using miRNAs and mRNAs differentially expressed in NMIBC and MIBC versus normal tissue according to previously validated informations regarding mRNA-miRNA interactions. NMIBC, non-muscle invasive bladder cancer; MIBC, muscle invasive bladder cancer.

Article Snippet: Total RNA (100 ng) from each sample was dephosphorylated, 3' end–labeled with Cy3-pCp, purified on Micro Bio-Spin columns, dried, and hybridized using the miRNA Microarray System labeling kit ( Illumina, San Diego, CA) and the Agilent Human miRNA Microarray Release 16.0 platform, which contains 1,205 human and 144 viral miRNAs [ ].

Techniques: Expressing

(A) mRNA expression. (B) miRNA expression. BC, bladder cancer; NMIBC, non-muscle invasive bladder cancer; MIBC, muscle invasive bladder cancer.

Journal: Oncotarget

Article Title: Identification of differentially expressed miRNAs and miRNA-targeted genes in bladder cancer

doi: 10.18632/oncotarget.24441

Figure Lengend Snippet: (A) mRNA expression. (B) miRNA expression. BC, bladder cancer; NMIBC, non-muscle invasive bladder cancer; MIBC, muscle invasive bladder cancer.

Article Snippet: Total RNA (100 ng) from each sample was dephosphorylated, 3' end–labeled with Cy3-pCp, purified on Micro Bio-Spin columns, dried, and hybridized using the miRNA Microarray System labeling kit ( Illumina, San Diego, CA) and the Agilent Human miRNA Microarray Release 16.0 platform, which contains 1,205 human and 144 viral miRNAs [ ].

Techniques: Expressing

(A) Genes associated with gene-miRNA interactions. (B) miRNAs associated with gene-miRNA interactions. BC, bladder cancer; NMIBC, non-muscle invasive bladder cancer; MIBC, muscle invasive bladder cancer.

Journal: Oncotarget

Article Title: Identification of differentially expressed miRNAs and miRNA-targeted genes in bladder cancer

doi: 10.18632/oncotarget.24441

Figure Lengend Snippet: (A) Genes associated with gene-miRNA interactions. (B) miRNAs associated with gene-miRNA interactions. BC, bladder cancer; NMIBC, non-muscle invasive bladder cancer; MIBC, muscle invasive bladder cancer.

Article Snippet: Total RNA (100 ng) from each sample was dephosphorylated, 3' end–labeled with Cy3-pCp, purified on Micro Bio-Spin columns, dried, and hybridized using the miRNA Microarray System labeling kit ( Illumina, San Diego, CA) and the Agilent Human miRNA Microarray Release 16.0 platform, which contains 1,205 human and 144 viral miRNAs [ ].

Techniques:

Expression profiling of miRNA-mRNA interacted target genes in NMIBC and MIBC

Journal: Oncotarget

Article Title: Identification of differentially expressed miRNAs and miRNA-targeted genes in bladder cancer

doi: 10.18632/oncotarget.24441

Figure Lengend Snippet: Expression profiling of miRNA-mRNA interacted target genes in NMIBC and MIBC

Article Snippet: Total RNA (100 ng) from each sample was dephosphorylated, 3' end–labeled with Cy3-pCp, purified on Micro Bio-Spin columns, dried, and hybridized using the miRNA Microarray System labeling kit ( Illumina, San Diego, CA) and the Agilent Human miRNA Microarray Release 16.0 platform, which contains 1,205 human and 144 viral miRNAs [ ].

Techniques: Expressing, Targeted Gene Expression

miR-19a is upregulated in the hypoxia-exposed CRC cells: (a) differentially expressed miRNAs between CRC cells cultured under hypoxic and normoxic conditions screened using a microarray analysis; (b) expression of miR-19a in HCT116 and SW480 cells cultured under hypoxic and normoxic conditions validated by RT-qPCR ( ∗ p < 0.05, two-way ANOVA); (c) expression of miR-19a in cancer and paracancerous tissues from CRC patients examined by RT-qPCR ( ∗ p < 0.05, paired t -test); (d) relevance of miR-19a expression to the survival of patients ( ∗ p < 0.05, Kaplan-Meier analysis); (e) relevance of miR-19a expression to the clinical characteristics of patients; (f) expression of miR-19a in HCT116 and SW480 and in normal NCM460 cells determined by RT-qPCR ( ∗ p < 0.05, one-way ANOVA). Data were presented as the mean ± SD from three independent experiments.

Journal: Analytical Cellular Pathology (Amsterdam)

Article Title: Hypoxia Enhances Activity and Malignant Behaviors of Colorectal Cancer Cells through the STAT3/MicroRNA-19a/PTEN/PI3K/AKT Axis

doi: 10.1155/2021/4132488

Figure Lengend Snippet: miR-19a is upregulated in the hypoxia-exposed CRC cells: (a) differentially expressed miRNAs between CRC cells cultured under hypoxic and normoxic conditions screened using a microarray analysis; (b) expression of miR-19a in HCT116 and SW480 cells cultured under hypoxic and normoxic conditions validated by RT-qPCR ( ∗ p < 0.05, two-way ANOVA); (c) expression of miR-19a in cancer and paracancerous tissues from CRC patients examined by RT-qPCR ( ∗ p < 0.05, paired t -test); (d) relevance of miR-19a expression to the survival of patients ( ∗ p < 0.05, Kaplan-Meier analysis); (e) relevance of miR-19a expression to the clinical characteristics of patients; (f) expression of miR-19a in HCT116 and SW480 and in normal NCM460 cells determined by RT-qPCR ( ∗ p < 0.05, one-way ANOVA). Data were presented as the mean ± SD from three independent experiments.

Article Snippet: The isolated miRNAs were labeled with Hy3 using a miRCURY microarray labeling kit (Exiqon) and then hybridized using a miRCURY LNA miRNA Array (v.8.0, Exiqon).

Techniques: Cell Culture, Microarray, Expressing, Quantitative RT-PCR